SAMHSA Extends Methadone Take-Home Flexibility
The Substance Abuse and Mental Health Services Administration (SAMHSA) announced that it will extend methadone take-home flexibilities for one year once the COVID-19 Public Health Emergency expires. This will continue the take-home flexibilities that were instituted in March 2020 to reduce the risk of COVID-19 among patients and health care providers. SAMHSA noted that it is also considering options for instituting this policy permanently, as these flexibilities had other positive impacts on individuals in Opioid Treatment Programs, including improved patient satisfaction, and very few incidents of misuse of medication.
Read more about the announcement here.